240 related articles for article (PubMed ID: 27464589)
1. Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis.
Kisiel JB; Konijeti GG; Piscitello AJ; Chandra T; Goss TF; Ahlquist DA; Farraye FA; Ananthakrishnan AN
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1778-1787.e8. PubMed ID: 27464589
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis.
Konijeti GG; Shrime MG; Ananthakrishnan AN; Chan AT
Gastrointest Endosc; 2014 Mar; 79(3):455-65. PubMed ID: 24262637
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
Ladabaum U; Mannalithara A
Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
[TBL] [Abstract][Full Text] [Related]
4. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
[TBL] [Abstract][Full Text] [Related]
5. Chromoendoscopy, Narrow-Band Imaging or White Light Endoscopy for Neoplasia Detection in Inflammatory Bowel Diseases.
Har-Noy O; Katz L; Avni T; Battat R; Bessissow T; Yung DE; Engel T; Koulaouzidis A; Eliakim R; Ben-Horin S; Kopylov U
Dig Dis Sci; 2017 Nov; 62(11):2982-2990. PubMed ID: 28965228
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People.
Redwood DG; Dinh TA; Kisiel JB; Borah BJ; Moriarty JP; Provost EM; Sacco FD; Tiesinga JJ; Ahlquist DA
Mayo Clin Proc; 2021 May; 96(5):1203-1217. PubMed ID: 33840520
[TBL] [Abstract][Full Text] [Related]
7. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.
Berger BM; Schroy PC; Dinh TA
Clin Colorectal Cancer; 2016 Sep; 15(3):e65-74. PubMed ID: 26792032
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening in patients with ulcerative and Crohn's colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy.
Hlavaty T; Huorka M; Koller T; Zita P; Kresanova E; Rychly B; Toth J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):680-9. PubMed ID: 21602687
[TBL] [Abstract][Full Text] [Related]
9. Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials.
Iannone A; Ruospo M; Wong G; Principi M; Barone M; Strippoli GFM; Di Leo A
Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1684-1697.e11. PubMed ID: 27890853
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population.
Ebner D; Kisiel J; Barnieh L; Sharma R; Smith NJ; Estes C; Vahdat V; Ozbay AB; Limburg P; Fendrick AM
J Med Econ; 2023; 26(1):1219-1226. PubMed ID: 37752872
[TBL] [Abstract][Full Text] [Related]
11. Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening.
Kisiel JB; Fendrick AM; Ebner DW; Ozbay AB; Vahdat V; Estes C; Limburg PJ
J Med Econ; 2024; 27(1):746-753. PubMed ID: 38686394
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Endoscopic Dysplasia Detection Techniques in Patients With Ulcerative Colitis: A Systematic Review and Network Meta-analysis.
Bessissow T; Dulai PS; Restellini S; Landry T; Bisschops R; Murad MH; Singh S
Inflamm Bowel Dis; 2018 Nov; 24(12):2518-2526. PubMed ID: 29846600
[TBL] [Abstract][Full Text] [Related]
13. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives.
Hathway JM; Miller-Wilson LA; Jensen IS; Ozbay B; Regan C; Jena AB; Weinstein MC; Parks PD
J Med Econ; 2020 Jun; 23(6):581-592. PubMed ID: 32063100
[No Abstract] [Full Text] [Related]
14. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
Prince M; Lester L; Chiniwala R; Berger B
World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
[TBL] [Abstract][Full Text] [Related]
15. Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis.
Klepp P; Tollisen A; Røseth A; Cvancarova Småstuen M; Andersen SN; Vatn M; Moum BA; Brackmann S
World J Gastroenterol; 2018 Sep; 24(35):4069-4076. PubMed ID: 30254411
[TBL] [Abstract][Full Text] [Related]
16. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
[TBL] [Abstract][Full Text] [Related]
17. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population.
Fisher DA; Karlitz JJ; Jeyakumar S; Smith N; Limburg P; Lieberman D; Fendrick AM
J Med Econ; 2021; 24(1):654-664. PubMed ID: 33902366
[TBL] [Abstract][Full Text] [Related]
18. Detecting dysplasia using white light endoscopy or chromoendoscopy in ulcerative colitis patients without primary sclerosing cholangitis: A systematic review and meta-analysis.
Azizi S; Al-Rubaye H; Turki MAA; Siddiqui MRS; Shanmuganandan AP; Ehsanullah B; Brar R; Abulafi AM
Int J Surg; 2018 Apr; 52():180-188. PubMed ID: 29462738
[TBL] [Abstract][Full Text] [Related]
19. A risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines.
Lutgens M; van Oijen M; Mooiweer E; van der Valk M; Vleggaar F; Siersema P; Oldenburg B
Gastrointest Endosc; 2014 Nov; 80(5):842-8. PubMed ID: 25088918
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
[No Abstract] [Full Text] [Related]
[Next] [New Search]
